Fibrin Clot Strength in Patients with Diabetes Mellitus Measured by Thrombelastography
Background. Patients with diabetes mellitus (DM) exhibit increased risk of recurrent myocardial infarction. Maximal clot strength measured by thrombelastography (TEG) is a risk factor for recurrent ischemic events. We hypothesized that diabetic subjects exhibit increased fibrin clot strength in plat...
Main Authors: | Benjamin T. Maatman, Glen Schmeisser, Rolf P. Kreutz |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2018/4543065 |
Similar Items
-
Prediction of Ischemic Events after Percutaneous Coronary Intervention: Thrombelastography Profiles and Factor XIIIa Activity
by: Rolf P. Kreutz, et al.
Published: (2018-04-01) -
Pulmonary arterial hypertension patients display normal kinetics of clot formation using thrombelastography
by: Mengyun Lu, et al.
Published: (2021-06-01) -
Reduced clot strength upon admission, evaluated by thrombelastography (TEG), in trauma patients is independently associated with increased 30-day mortality
by: Thomsen Annemarie B, et al.
Published: (2011-09-01) -
Microrheology of fibrin clots
by: Allan, Peter
Published: (2012) -
Thrombelastography and Thrombelastometry
by: Duraj Lukas, et al.
Published: (2013-03-01)